Cargando…
Efferocytic Defects in Early Atherosclerosis Are Driven by GATA2 Overexpression in Macrophages
The loss of efferocytosis—the phagocytic clearance of apoptotic cells—is an initiating event in atherosclerotic plaque formation. While the loss of macrophage efferocytosis is a prerequisite for advanced plaque formation, the transcriptional and cellular events in the pre-lesion site that drive thes...
Autores principales: | Yin, Charles, Vrieze, Angela M., Rosoga, Mara, Akingbasote, James, Pawlak, Emily N., Jacob, Rajesh Abraham, Hu, Jonathan, Sharma, Neha, Dikeakos, Jimmy D., Barra, Lillian, Nagpal, A. Dave, Heit, Bryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644460/ https://www.ncbi.nlm.nih.gov/pubmed/33193444 http://dx.doi.org/10.3389/fimmu.2020.594136 |
Ejemplares similares
-
Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes
por: Lam, Austin Le, et al.
Publicado: (2021) -
Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
por: Flores, Alyssa M., et al.
Publicado: (2020) -
The effect of HLA-DRB1*04:01 on a mouse model of atherosclerosis
por: Blackler, Garth, et al.
Publicado: (2023) -
Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect
por: Sha, Xuan, et al.
Publicado: (2022) -
The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis
por: Jarr, Kai-Uwe, et al.
Publicado: (2022)